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In Memoriam
Norton Zinder (1929–2012)
Geneticist
Z
inder, a superb geneticist (who also embraced biochem-
istry), died on February 3, 2012, following a long illness.
He was 83. Zinder came of age at the dawn of microbial
genetics. A prodigy with an eidetic memory, he was only 15
when he graduated from the Bronx High School of Science,
where he built his ﬁrst incubator for growing bacteria (a 60-W
light bulb in a box with a thermostat). After earning his un-
dergraduate degree at Columbia University only 3 years later,
he migrated to the University of Wisconsin in Madison; his
sweetheart and bride, Marilyn,soon joined him. As a graduate
student with Joshua Lederberg (another Bronx-born wun-
derkind a few years his senior), he commenced to extend
Lederberg’s studies of bacterial conjugation. While trying
to understand why his Salmonella were not behaving prop-
erly, Norton discovered transduction, the process by which
viruses carry DNA from one organism to another. Norton
always was sure that animal viruses do the same with their
eukaryotic host. That is now well established. The Perspectives
article that Norton wrote for GENETICS (Genetics 1992 132:
291–294) marking the 40th anniversary of the discovery of
transduction provides a captivating description of how the
combination of chance, insight, and careful experimentation
led to that discovery and his deduction that the process is
mediated by phage. Norton also participated in the discovery
of penicillin selection and co-authored a landmark paper with
Lederberg, “Concentration of biochemical mutants of bacteria
with penicillin” (J Am Chem Soc. 1948 70: 4267). Years later he
d e l i g h t e di ns h o w i n gv i s i t o r saﬁlter paper that he had re-
trieved from an old lab notebook that he used to replica-
plate some of those mutants.
After joining the faculty of The Rockefeller University in
1952, Zinder and Tim Loeb, his ﬁrst student, isolated
bacteriophages that could grow only on strains carrying
the F (fertility) factor responsible for bacterial sex. Thus was
the ﬁrst phage with an RNA genome (f2) identiﬁed. Access
to large quantities of a homogeneous RNA opened the door
to many fundamental questions, which Norton and his
students attacked with vigor. Always there were mutants—
and, once they knew that the genome was the message,
biochemistry—that revealed the nature of nonsense sup-
pressors and how protein synthesis initiates and terminates.
In the late 1960s, a NOVA television program, “Stop or Go,”
explained some of these discoveries. Norton and his lab
members reenacted their search for conditional-lethal f2
mutants, their elation at ﬁnding them, and the experiments
that led them to suppressor tRNAs, the n-formyl methionine
that initiates protein synthesis, and translation stop codons.
The availability of pure f2 RNA also led to the identiﬁ-
cation of RNase III by a frustrated student, the late Hugh
Robertson, who was trying to synthesize active f2 replicase
in vitro. Expecting to ﬁnd an increase in double-stranded
RNA upon replicase action, Robertson instead kept seeing
a decrease. Norton insisted that something in the protein
synthesis extracts must be digesting naturally double-
stranded regions of f2 RNA, which led to the discovery of
the ﬁrst enzyme speciﬁc for double-stranded RNA. Many
years later its eukaryotic relative was found: Dicer, the en-
zyme involved in the generation of siRNA.
Along with f2, Zinder and Loeb discovered ﬁlamentous
phage f1, containing a single-stranded DNA genome. In ad-
dition to providing easy access to single-stranded DNA for
sequencing, f1 made possible his development of phagemids
(plasmid-ﬁlamentous phage hybrids), which led to remark-
able biotechnology achievements such as phage display and,
more recently, the nano-battery. Having determined (via
mutants, of course) that two sites on double-stranded f1
replicative form DNA made it susceptible to the “B” restric-
tion system described by Werner Arber and colleagues
(Arber and Linn 1969), Zinder was eager to explore host
restriction and modiﬁcation at a biochemical level. A puz-
zling observation was that the EcoB enzyme did not produce
a clear pattern of recognizable fragments, even though
Hamilton Smith at Johns Hopkins was obtaining clean DNA
fragments using a restriction enzyme from Haemophilus.
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Genetics, Vol. 191, 291–292 May 2012 291This mystery was solved when it was found that EcoB
requires ATP but the Haemophilus enzyme does not, and that
t h eA T P a s ea c t i v i t yo fEcoB is dependent on the length of DNA
p r e s e n t e dt oi t .I tm a yh a v eb e e ni nt h i sc o n t e x tt h a tN o r t o n
ruefully admitted the power of a “trivial” biochemical experi-
ment to overthrow the most elegant genetic deduction. After
some head scratching, the conclusion became clear: the genet-
ically deﬁned sites on f1 DNA are entry sites for the nuclease,
which uses ATP to travel along the DNA and eventually cut it.
That made these type I restriction enzymes interesting, but not
very useful; the utility of type II restriction enzymes, such as
the original from Haemophilus,i sd i f ﬁcult to overestimate.
Norton retained the youthful informality of a wunderkind
even as he matured. He could often be found perched cross-
legged on the horizontal freezer in the open “big lab” that he
designed, talking with students (whom he referred to as
“Zinder Kinder”), scrutinizing their plates. Former post-doc
(now a Duke University emeritus professor) Robert E. Webster
remembers that Norton “was always motivating you by be-
ing around and getting you thinking about the big picture.
With Norton, it was not hard to always see the forest and
not just the trees.” His lively intelligence did not allow for
linear conversation: his ideas bounced and ricocheted in many
directions. An ability to follow his intellectual leaps and dis-
continuities may have been what selected for the outstand-
ingly able students whom he trained. One of them, current
Rockefeller University professor Jeffrey Ravetch, eulogized
Norton: “He expected greatness; he demanded independence,
creativity, and critical thinking.”
Zinder’s restless intelligence led him to wider stages on
which he could be outspoken and brutally frank. When he
became aware that the tumors of cancer patients treated with
an initially effective drug eventually became resistant to that
drug, necessitating a second drug to which the tumor became
resistant, he crossed the street to the Sloan-Kettering Institute
for Cancer Research to explain mutation frequencies to the
doctors and why treating with multiple drugs simultaneously
should prevent the appearance of “escape” mutants. In science
policy, he argued for proceeding slowly with recombinant DNA
experiments until potential pitfalls could be discerned; he
chaired a U.S. Army committee and guided generals to low-
risk methods for disposal of aging chemical weapons. And he
joined Jim Watson, his great friend (and one-time competi-
tor), in supporting the National Institutes of Health human
genome project at a time when many scientists opposed it as
an expensive sink for research resources.
Zinder is survived by two sons, Stephen, a professor of
microbiology at Cornell University, and Michael, a lawyer in
New York; his daughters-in-law Chris and Charlotte; and
ﬁve grandsons. His wife, Marilyn, died in 2004.
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